• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于轻微肝性脑病的实践模式与认知的调查:印度全国性调查

A survey of patterns of practice and perception of minimal hepatic encephalopathy: a nationwide survey in India.

作者信息

Sharma Praveen, Sharma Barjesh C

机构信息

Department of Gastroenterology and Hepatology, Sir Ganga Ram Hospital, New Delhi, India.

出版信息

Saudi J Gastroenterol. 2014 Sep-Oct;20(5):304-8. doi: 10.4103/1319-3767.141692.

DOI:10.4103/1319-3767.141692
PMID:25253366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4196346/
Abstract

BACKGROUND/AIM: Minimal hepatic encephalopathy (MHE) leads to overt hepatic encephalopathy (HE) and impairs quality of life in patients with cirrhosis. Awareness of MHE and its management among physicians is not known.

PATIENTS AND METHODS

We conducted a survey among 673 physicians in India from academic and nonacademic institutes to understand the clinical burden, perceived severity, management patterns, and the barriers to providing care for this condition.

RESULTS

Overall awareness of MHE in this survey was 75% (n = 504). Awareness of MHE was significantly higher in physicians working in teaching hospitals compared with those in nonteaching hospitals (79% vs 71%, P = 0.02). Similarly, gastroenterologists were more aware of MHE compared with nongastroenterologists (91% vs 66%, P = 0.001). Only 6.3% physicians screened all of their patients for MHE, whereas frequency of testing for MHE, either being nil or less than 10% of their patients was 64.7%. The most common test was paper and pencil test (86%) and the reason for nonscreening was nonavailability of time to test and also equipment or method (81%). A majority of physicians (88%) think that MHE affects quality of life. Physicians (61%) had an opinion that there should be some registry of MHE regardless of the cost and effort involved. Lactulose was used in 93% of cases, followed by rifaximin (82%) in the management of MHE.

CONCLUSION

The overall awareness of MHE was 75% and it was significantly more in physicians of academic institutes. Despite awareness of its effect on quality of life, a majority of physicians did not test for MHE in their day-to-day practice.

摘要

背景/目的:轻微肝性脑病(MHE)可发展为显性肝性脑病(HE),并损害肝硬化患者的生活质量。目前尚不清楚医生对MHE及其管理的认知情况。

患者与方法

我们对印度673名来自学术机构和非学术机构的医生进行了一项调查,以了解MHE的临床负担、感知严重程度、管理模式以及提供该疾病护理的障碍。

结果

本次调查中,医生对MHE的总体认知率为75%(n = 504)。与非教学医院的医生相比,教学医院的医生对MHE的认知率显著更高(79%对71%,P = 0.02)。同样,与非胃肠病学家相比,胃肠病学家对MHE的认知更多(91%对66%,P = 0.001)。只有6.3%的医生对所有患者进行MHE筛查,而MHE检测频率为零或低于其患者10%的比例为64.7%。最常用的检测方法是纸笔测试(86%),未进行筛查的原因是没有时间进行检测以及缺乏设备或方法(81%)。大多数医生(88%)认为MHE会影响生活质量。61%的医生认为无论成本和工作量如何,都应该建立MHE登记册。在MHE的管理中,93%的病例使用了乳果糖,其次是利福昔明(82%)。

结论

医生对MHE的总体认知率为75%,学术机构的医生认知率显著更高。尽管认识到其对生活质量的影响,但大多数医生在日常实践中并未对MHE进行检测。

相似文献

1
A survey of patterns of practice and perception of minimal hepatic encephalopathy: a nationwide survey in India.一项关于轻微肝性脑病的实践模式与认知的调查:印度全国性调查
Saudi J Gastroenterol. 2014 Sep-Oct;20(5):304-8. doi: 10.4103/1319-3767.141692.
2
Management of hepatic encephalopathy in Germany: a survey among physicians.德国肝性脑病的管理:一项针对医生的调查
Z Gastroenterol. 2020 Jan;58(1):49-56. doi: 10.1055/a-1010-6974. Epub 2020 Jan 13.
3
Minimal hepatic encephalopathy in cirrhosis- how long to treat?肝硬化中的轻微肝性脑病——治疗多久?
Ann Hepatol. 2017;16(1):115-122. doi: 10.5604/16652681.1226822.
4
Between reality and the guidelines: A survey on perception, diagnosis and management of hepatic encephalopathy in 201 Italian specialist centres.现实与指南之间:对201家意大利专科中心肝性脑病认知、诊断及管理情况的调查
Dig Liver Dis. 2017 Jul;49(7):828-830. doi: 10.1016/j.dld.2017.04.016. Epub 2017 May 1.
5
Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.利福昔明与乳果糖治疗轻微肝性脑病的对比研究
Liver Int. 2016 Mar;36(3):378-85. doi: 10.1111/liv.12921. Epub 2015 Aug 17.
6
Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.目前针对肝硬化患者轻微肝性脑病的治疗方法。
World J Gastroenterol. 2021 Jun 14;27(22):3050-3063. doi: 10.3748/wjg.v27.i22.3050.
7
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.肝硬化患者轻微肝性脑病的患病率:一项在印度开展的横断面、临床流行病学、多中心、全国性研究:PREDICT研究
J Clin Exp Hepatol. 2019 Jul-Aug;9(4):476-483. doi: 10.1016/j.jceh.2018.09.009. Epub 2018 Oct 15.
8
Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial.一项随机试验中营养疗法对肝硬化合并轻微肝性脑病患者的疗效
Clin Gastroenterol Hepatol. 2016 Mar;14(3):454-460.e3; quiz e33. doi: 10.1016/j.cgh.2015.09.028. Epub 2015 Oct 8.
9
Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.演变的概念:轻微肝性脑病的负面影响和肝硬化患者预防的作用。
Clin Ther. 2013 Sep;35(9):1458-73. doi: 10.1016/j.clinthera.2013.07.421. Epub 2013 Aug 22.
10
Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.肝外门静脉阻塞患者轻微肝性脑病的自然病史。
Am J Gastroenterol. 2009 Apr;104(4):885-90. doi: 10.1038/ajg.2009.84. Epub 2009 Mar 17.

引用本文的文献

1
EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients.EncephalApp 斯特鲁普测验用于突尼斯肝硬化患者隐匿性肝性脑病的筛查。
F1000Res. 2023 Sep 1;11:686. doi: 10.12688/f1000research.121781.2. eCollection 2022.
2
Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients.轻微肝性脑病和鳖甲软肝方与非酒精性肝硬化患者首次医院再入院有关。
Evid Based Complement Alternat Med. 2021 May 7;2021:6652858. doi: 10.1155/2021/6652858. eCollection 2021.
3
Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy.

本文引用的文献

1
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.一项比较乳果糖、益生菌和 L-鸟氨酸 L-天冬氨酸治疗轻微型肝性脑病的随机对照试验。
Eur J Gastroenterol Hepatol. 2011 Aug;23(8):725-32. doi: 10.1097/MEG.0b013e32834696f5.
2
Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).利福昔明可改善轻微肝性脑病患者的心理测量学表现和健康相关生活质量(RIME 试验)。
Am J Gastroenterol. 2011 Feb;106(2):307-16. doi: 10.1038/ajg.2010.455. Epub 2010 Dec 14.
3
一种用于识别轻微型和预测显性肝性脑病的简易生活质量评分的验证
Hepatol Commun. 2020 Jul 3;4(9):1353-1361. doi: 10.1002/hep4.1555. eCollection 2020 Sep.
4
MHE Testing in Real World Scenario.真实场景中的轻微肝性脑病检测
J Clin Exp Hepatol. 2018 Dec;8(4):438-440. doi: 10.1016/j.jceh.2018.04.010. Epub 2018 May 5.
5
Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.肝硬化患者轻微肝性脑病的患病率及相关因素
J Clin Exp Hepatol. 2018 Jun;8(2):156-161. doi: 10.1016/j.jceh.2017.06.005. Epub 2017 Jun 20.
6
Probiotics for people with hepatic encephalopathy.用于肝性脑病患者的益生菌。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD008716. doi: 10.1002/14651858.CD008716.pub3.
7
Covert Hepatic Encephalopathy: Can My Patient Drive?隐匿性肝性脑病:我的患者可以开车吗?
J Clin Gastroenterol. 2017 Feb;51(2):118-126. doi: 10.1097/MCG.0000000000000764.
Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
益生菌酸奶用于治疗轻微肝性脑病。
Am J Gastroenterol. 2008 Jul;103(7):1707-15. doi: 10.1111/j.1572-0241.2008.01861.x.
4
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.乳果糖和益生菌治疗轻微肝性脑病的开放标签随机对照试验
Eur J Gastroenterol Hepatol. 2008 Jun;20(6):506-11. doi: 10.1097/MEG.0b013e3282f3e6f5.
5
Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations.轻微肝性脑病:事故和交通违规的诱因
Am J Gastroenterol. 2007 Sep;102(9):1903-9. doi: 10.1111/j.1572-0241.2007.01424.x. Epub 2007 Jul 19.
6
Testing for minimal hepatic encephalopathy in the United States: An AASLD survey.美国轻微肝性脑病的检测:美国肝病研究学会的一项调查。
Hepatology. 2007 Mar;45(3):833-4. doi: 10.1002/hep.21515.
7
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.乳果糖可改善轻度肝性脑病肝硬化患者的认知功能及与健康相关的生活质量。
Hepatology. 2007 Mar;45(3):549-59. doi: 10.1002/hep.21533.
8
Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.肝性脑病——定义、命名、诊断及量化:1998年于维也纳召开的第11届世界胃肠病学大会工作小组最终报告
Hepatology. 2002 Mar;35(3):716-21. doi: 10.1053/jhep.2002.31250.
9
Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.肝硬化患者亚临床肝性脑病的患病率及自然病史
J Gastroenterol Hepatol. 2001 May;16(5):531-5. doi: 10.1046/j.1440-1746.2001.02487.x.
10
Screening of subclinical hepatic encephalopathy.亚临床肝性脑病的筛查
J Hepatol. 2000 May;32(5):748-53. doi: 10.1016/s0168-8278(00)80243-3.